Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Johnson & Johnson : Raymond James Adjusts Price Target on Johnson & Johnson to $178 from $183, Keeps Outperform Rating

10/20/2021 | 11:31am EST


ę MT Newswires 2021
All news about JOHNSON & JOHNSON
10:32aRaymond James Adjusts Johnson & Johnson's Price Target to $185 From $178, Keeps Outperf..
MT
08:47aGenmab Announces Net Sales of DARZALEX for 2021
AQ
03:53aCOVID-19 Severity Appears Lower With Omicron, But High Hospitalization Volume Could Str..
MT
01/25Nvidia, General Electric fall; IBM, American Express rise
AQ
01/25Health Care Stocks Still Trying to Overcome Midday Slide
MT
01/25US Labor Department's OSHA Revokes COVID-19 Vaccination Order for Large Employers
MT
01/25Health Care Stocks Resisting Steeper Tuesday Market Losses
MT
01/25GLOBAL MARKETS LIVE : Credit Suisse, Unilever, Nvidia, Tesla, American Express...
01/25Prescription drugs, medical devices boost J&J in Q4
AQ
01/25WALL STREET STOCK EXCHANGE : A roller-coaster week as Fed decision looms
More news
Analyst Recommendations on JOHNSON & JOHNSON
More recommendations
Financials (USD)
Sales 2021 94 304 M - -
Net income 2021 22 542 M - -
Net cash 2021 815 M - -
P/E ratio 2021 19,9x
Yield 2021 2,48%
Capitalization 441 B 441 B -
EV / Sales 2021 4,67x
EV / Sales 2022 4,36x
Nbr of Employees 134 500
Free-Float 84,3%
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | MarketScreener
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Last Close Price 167,63 $
Average target price 183,22 $
Spread / Average Target 9,30%
EPS Revisions
Managers and Directors
Joaquin Duato Chief Executive Officer & Director
Joseph J. Wolk Chief Financial Officer & Executive Vice President
Alex Gorsky Executive Chairman
James D. Swanson Global Chief Information Officer & Executive VP
Charles O. Prince Independent Director
Sector and Competitors
1st jan.Capi. (M$)
JOHNSON & JOHNSON-2.01%441 302
ROCHE HOLDING AG-8.68%304 745
PFIZER, INC.-11.02%294 900
ABBVIE INC.-1.71%235 287
ELI LILLY AND COMPANY-13.31%217 093
NOVO NORDISK A/S-14.94%215 777